ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
1.460
-0.020 (-1.35%)
Apr 29, 2026, 11:50 AM EDT - Market open
ProQR Therapeutics Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 92.41 | 149.41 | 118.93 | 94.78 | 187.52 | Upgrade
|
| Cash & Short-Term Investments | 92.41 | 149.41 | 118.93 | 94.78 | 187.52 | Upgrade
|
| Cash Growth | -38.15% | 25.63% | 25.48% | -49.46% | 147.27% | Upgrade
|
| Accounts Receivable | - | - | - | 56.25 | - | Upgrade
|
| Other Receivables | 5.09 | 2.03 | 1.27 | 0.98 | 0.82 | Upgrade
|
| Receivables | 5.09 | 2.03 | 1.27 | 57.24 | 0.82 | Upgrade
|
| Prepaid Expenses | 2.63 | 2.41 | 0.79 | 2.45 | 3.14 | Upgrade
|
| Total Current Assets | 100.13 | 153.85 | 120.99 | 154.46 | 191.48 | Upgrade
|
| Property, Plant & Equipment | 12.63 | 14.11 | 16.9 | 16.24 | 17.47 | Upgrade
|
| Long-Term Investments | - | - | - | 0.62 | 0.63 | Upgrade
|
| Total Assets | 112.76 | 167.96 | 137.88 | 171.32 | 209.58 | Upgrade
|
| Accounts Payable | 0.3 | 0.02 | 1.54 | 0.39 | 0.19 | Upgrade
|
| Accrued Expenses | - | 1.48 | 1.66 | 1.12 | 1.23 | Upgrade
|
| Current Portion of Long-Term Debt | 4.87 | 4.58 | - | 2.5 | 4.77 | Upgrade
|
| Current Portion of Leases | 1.55 | 1.57 | 1.61 | 1.39 | 1.53 | Upgrade
|
| Current Unearned Revenue | 17.55 | 21.94 | 20.57 | 5.64 | 5.12 | Upgrade
|
| Other Current Liabilities | 8.17 | 9.32 | 8.82 | 9.95 | 14.76 | Upgrade
|
| Total Current Liabilities | 32.44 | 38.9 | 34.2 | 20.99 | 27.6 | Upgrade
|
| Long-Term Debt | - | - | 4.29 | 4.27 | 39.32 | Upgrade
|
| Long-Term Leases | 9.55 | 11.07 | 13.83 | 13.81 | 14.75 | Upgrade
|
| Long-Term Unearned Revenue | 21.39 | 29.43 | 44.17 | 65.57 | 14.69 | Upgrade
|
| Total Liabilities | 63.38 | 79.4 | 96.49 | 104.64 | 96.35 | Upgrade
|
| Common Stock | 4.31 | 4.31 | 3.37 | 3.37 | 3 | Upgrade
|
| Additional Paid-In Capital | 483.88 | 483.81 | 412.89 | 412.54 | 398.31 | Upgrade
|
| Retained Earnings | -467.51 | -427.16 | -400.85 | -379.11 | -317.77 | Upgrade
|
| Comprehensive Income & Other | 28.69 | 27.6 | 25.98 | 30.26 | 30.3 | Upgrade
|
| Total Common Equity | 49.37 | 88.56 | 41.39 | 67.07 | 113.83 | Upgrade
|
| Minority Interest | - | - | - | -0.38 | -0.6 | Upgrade
|
| Shareholders' Equity | 49.37 | 88.56 | 41.39 | 66.68 | 113.23 | Upgrade
|
| Total Liabilities & Equity | 112.76 | 167.96 | 137.88 | 171.32 | 209.58 | Upgrade
|
| Total Debt | 15.96 | 17.22 | 19.73 | 21.97 | 60.37 | Upgrade
|
| Net Cash (Debt) | 76.45 | 132.19 | 99.19 | 72.8 | 127.15 | Upgrade
|
| Net Cash Growth | -42.17% | 33.27% | 36.24% | -42.74% | 205.94% | Upgrade
|
| Net Cash Per Share | 0.73 | 1.54 | 1.22 | 1.02 | 1.98 | Upgrade
|
| Filing Date Shares Outstanding | 105.36 | 105.21 | 81.35 | 80.82 | 71.29 | Upgrade
|
| Total Common Shares Outstanding | 105.36 | 105.21 | 81.35 | 80.82 | 71.29 | Upgrade
|
| Working Capital | 67.69 | 114.94 | 86.78 | 133.47 | 163.89 | Upgrade
|
| Book Value Per Share | 0.47 | 0.84 | 0.51 | 0.83 | 1.60 | Upgrade
|
| Tangible Book Value | 49.37 | 88.56 | 41.39 | 67.07 | 113.83 | Upgrade
|
| Tangible Book Value Per Share | 0.47 | 0.84 | 0.51 | 0.83 | 1.60 | Upgrade
|
| Buildings | 24.19 | 23.79 | 24.78 | 22.86 | 22.23 | Upgrade
|
| Machinery | 7.53 | 6.82 | 5.91 | 4.91 | 4.25 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.